SG47763A1 - [(Benzodioxan benzofuran or benzopyran) alkylamino] alkyl substituted guanidines - Google Patents

[(Benzodioxan benzofuran or benzopyran) alkylamino] alkyl substituted guanidines

Info

Publication number
SG47763A1
SG47763A1 SG1996004264A SG1996004264A SG47763A1 SG 47763 A1 SG47763 A1 SG 47763A1 SG 1996004264 A SG1996004264 A SG 1996004264A SG 1996004264 A SG1996004264 A SG 1996004264A SG 47763 A1 SG47763 A1 SG 47763A1
Authority
SG
Singapore
Prior art keywords
benzodioxan
benzopyran
benzofuran
alkylamino
alkyl substituted
Prior art date
Application number
SG1996004264A
Other languages
English (en)
Inventor
Van Guy Rosalia Eugene Lommen
De Marcel Frans Leopold Bruyn
Walter Jacobus Joseph Janssens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SG47763A1 publication Critical patent/SG47763A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Pyrane Compounds (AREA)
SG1996004264A 1992-02-27 1993-02-19 [(Benzodioxan benzofuran or benzopyran) alkylamino] alkyl substituted guanidines SG47763A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84256092A 1992-02-27 1992-02-27

Publications (1)

Publication Number Publication Date
SG47763A1 true SG47763A1 (en) 1998-04-17

Family

ID=25287639

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004264A SG47763A1 (en) 1992-02-27 1993-02-19 [(Benzodioxan benzofuran or benzopyran) alkylamino] alkyl substituted guanidines

Country Status (37)

Country Link
US (4) US5541180A (zh)
EP (1) EP0639192B1 (zh)
JP (1) JP2779268B2 (zh)
KR (1) KR100190300B1 (zh)
CN (1) CN1038032C (zh)
AP (1) AP416A (zh)
AT (1) ATE138064T1 (zh)
AU (1) AU664237B2 (zh)
BG (1) BG62052B1 (zh)
CA (1) CA2117483C (zh)
CZ (1) CZ282092B6 (zh)
DE (1) DE69302687T2 (zh)
DK (1) DK0639192T3 (zh)
EE (1) EE03029B1 (zh)
ES (1) ES2087721T3 (zh)
FI (1) FI109122B (zh)
GR (1) GR3019927T3 (zh)
HR (1) HRP930235B1 (zh)
HU (2) HU222495B1 (zh)
IL (1) IL104868A (zh)
LT (1) LT3049B (zh)
LV (1) LV10715B (zh)
MX (1) MX9301053A (zh)
MY (1) MY110627A (zh)
NO (1) NO306255B1 (zh)
NZ (1) NZ249124A (zh)
OA (1) OA10095A (zh)
PH (1) PH31295A (zh)
PL (1) PL174736B1 (zh)
RO (1) RO115630B1 (zh)
RU (1) RU2121999C1 (zh)
SG (1) SG47763A1 (zh)
SI (1) SI9300097B (zh)
SK (1) SK280166B6 (zh)
TW (1) TW225531B (zh)
WO (1) WO1993017017A1 (zh)
ZA (1) ZA931404B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228673B1 (en) * 1993-08-19 2013-05-28 Janssen Pharmaceutica Nv Vasoconstrictive substituted dihydropyranopyridines, process for producing them and pharmaceutical compositions containing them
KR100330696B1 (ko) * 1993-08-19 2002-10-04 얀센 파마슈티카 엔.브이. 혈관수축성디하이드로벤조피란유도체
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
US6054462A (en) * 1994-04-13 2000-04-25 Janssen Pharmaceutica, N.V. Intranasal antimigraine compositions
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
ATE210657T1 (de) * 1994-10-14 2001-12-15 Merck Patent Gmbh Zns wirksames (r)-(-)-2-(5-(4-fluorophenyl)-3- pyridylmethylaminomethyl)chroman
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
WO1996041632A1 (en) * 1995-06-08 1996-12-27 Janssen Pharmaceutica N.V. Starch microsphere anti migraine composition
FR2752735B1 (fr) * 1996-09-05 1998-10-02 Synthelabo Utilisation de derives de benzofurane pour obtenir un medicament destine au traitement de l'insuffisance veineuse et de l'ulcere veineux
TW504510B (en) 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
JP2003501427A (ja) 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アミノアルキル置換(ベンゾジオキサン、ベンゾフランもしくはベンゾピラン)誘導体
EA004648B1 (ru) 1999-06-02 2004-06-24 Янссен Фармацевтика Н.В. Пирролидинил-, пиперидинил- или гомопиперидинилзамещенные производные, способ их получения, их применение в медицине, содержащая их фармацевтическая композиция и способ ее получения
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
JP2004517081A (ja) * 2000-11-29 2004-06-10 イーライ・リリー・アンド・カンパニー 1−(2−m−メタンスルホンアミドフェニルエチル)−4−(m−トリフルオロメチルフェニル)ピペラジンならびにその医薬的に許容しうる塩および溶媒和物
IL157254A0 (en) * 2001-02-23 2004-02-19 Merck & Co Inc N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
US7872030B2 (en) 2001-07-26 2011-01-18 Merck Patent Gmbh Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
ES2262840T3 (es) * 2001-09-19 2006-12-01 Merck Patent Gmbh Nuevo uso de los aminometil cromanos substituidos.
AU2004208821B2 (en) * 2003-01-31 2009-01-15 Zimmer Orthobiologics Inc. Hydrogel compositions comprising nucleus pulposus tissue
ZA200507112B (en) * 2003-03-31 2007-03-28 Taisho Pharmaceutical Co Ltd Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
EP1464335A3 (en) * 2003-03-31 2007-05-09 Taisho Pharmaceutical Co. Ltd. Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
PL1976509T3 (pl) * 2006-01-18 2015-07-31 Evolva Sa Modulatory PPAR
CN105061392B (zh) * 2015-07-20 2017-07-18 上海现代哈森(商丘)药业有限公司 一种硫酸胍生合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL296841A (zh) * 1962-08-20
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
GB1411531A (en) * 1972-10-24 1975-10-29 Lafon Labor Amino derivatives of 1,4-benzodioxan
GR71865B (zh) * 1978-03-20 1983-07-07 Ciba Geigy
US4405922A (en) * 1979-05-23 1983-09-20 Hitachi Koki Company, Limited Failure detection circuit for impact printers or the like
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
CA2011899A1 (en) * 1989-03-13 1990-09-13 Masaaki Toda Benzopyran derivatives
WO1994017017A1 (en) * 1991-07-15 1994-08-04 Exxon Research And Engineering Company Benzene removal from gasoline boiling range streams
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate

Also Published As

Publication number Publication date
AP9300493A0 (en) 1993-04-30
IL104868A0 (en) 1993-06-10
NO943186L (no) 1994-08-29
BG98870A (bg) 1995-03-31
HRP930235B1 (en) 1999-04-30
DK0639192T3 (da) 1996-08-19
EP0639192B1 (en) 1996-05-15
IL104868A (en) 1998-01-04
MX9301053A (es) 1994-03-31
AP416A (en) 1995-09-29
FI943928A0 (fi) 1994-08-26
FI943928A (fi) 1994-08-26
BG62052B1 (bg) 1999-01-29
KR100190300B1 (ko) 1999-06-01
CS202094A3 (en) 1995-01-18
TW225531B (zh) 1994-06-21
RU2121999C1 (ru) 1998-11-20
AU664237B2 (en) 1995-11-09
NZ249124A (en) 1995-08-28
WO1993017017A1 (en) 1993-09-02
PH31295A (en) 1998-07-06
CA2117483A1 (en) 1993-09-02
DE69302687D1 (de) 1996-06-20
HU9402464D0 (en) 1994-10-28
LV10715B (en) 1995-12-20
SI9300097A (en) 1993-09-30
CN1079470A (zh) 1993-12-15
ZA931404B (en) 1994-08-26
NO943186D0 (no) 1994-08-29
HU222495B1 (hu) 2003-07-28
SK102994A3 (en) 1995-07-11
EE03029B1 (et) 1997-08-15
CA2117483C (en) 2001-01-09
LTIP367A (lt) 1994-04-25
CZ282092B6 (cs) 1997-05-14
US5688952A (en) 1997-11-18
RU94041210A (ru) 1996-07-10
US5541180A (en) 1996-07-30
LV10715A (lv) 1995-06-20
US5624952A (en) 1997-04-29
HUT71129A (en) 1995-11-28
DE69302687T2 (de) 1996-11-14
LT3049B (en) 1994-10-25
CN1038032C (zh) 1998-04-15
JP2779268B2 (ja) 1998-07-23
JPH07504408A (ja) 1995-05-18
GR3019927T3 (en) 1996-08-31
EP0639192A1 (en) 1995-02-22
HU211742A9 (en) 1995-12-28
AU3499193A (en) 1993-09-13
MY110627A (en) 1998-09-30
HRP930235A2 (en) 1997-10-31
ATE138064T1 (de) 1996-06-15
OA10095A (en) 1996-12-18
RO115630B1 (ro) 2000-04-28
NO306255B1 (no) 1999-10-11
US5607949A (en) 1997-03-04
FI109122B (fi) 2002-05-31
SK280166B6 (sk) 1999-09-10
ES2087721T3 (es) 1996-07-16
SI9300097B (en) 2001-12-31
PL174736B1 (pl) 1998-09-30

Similar Documents

Publication Publication Date Title
SG47763A1 (en) [(Benzodioxan benzofuran or benzopyran) alkylamino] alkyl substituted guanidines
EP0434249A3 (en) Benzofuran derivatives
PL309228A1 (en) Method of obtaining benzopyran compounds
GB2211501B (en) Novel antihypertensive benzopyran derivatives
ZA926549B (en) Novel benzopyran derivatives
AU8215287A (en) Herbicidal substituted benzofurans and benzopyrans
IL94256A0 (en) Chroman derivatives
ZA906144B (en) Chroman derivatives
ZA888075B (en) Novel antihypertensive benzopyran derivatives
ZA905773B (en) Chroman derivatives
ZA937633B (en) Benzofuran derivatives
ZA905325B (en) Chroman derivatives
EP0435322A3 (en) Benzofuran derivatives
GB8812964D0 (en) Pyran compounds
IL95143A0 (en) Preparation of an antihypertensive benzopyran derivative
PL309361A1 (en) Benzopyran derivatives
AU5525890A (en) Novel antihypertensive benzopyran derivatives
EP0420470A3 (en) Naphthopyran compounds
IE901319L (en) Antihypertensive benzopyrans
GB9025068D0 (en) Lactone compounds
IE892690L (en) Benzopyrans
ZA909638B (en) Benzofuran derivatives
IE891802L (en) Benzopyran vasodilators
IL89618A0 (en) Chromone derivatives
IE891946L (en) Chromans